Indivior Pharmaceuticals Files 8-K on Financials
Ticker: INDV · Form: 8-K · Filed: Apr 30, 2026 · CIK: 0001625297
| Field | Detail |
|---|---|
| Company | Indivior Pharmaceuticals, Inc. (INDV) |
| Form Type | 8-K |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-K, reporting
TL;DR
Indivior dropped its 8-K on 4/30/26 with financial results. Check the exhibits for details.
AI Summary
Indivior Pharmaceuticals, Inc. filed an 8-K on April 30, 2026, reporting results of operations and financial condition. The filing includes various exhibits, such as financial statements and graphical representations, likely detailing the company's performance for the period ending April 30, 2026.
Why It Matters
This filing provides investors with crucial, up-to-date information on Indivior's financial performance and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing with no immediate indication of significant new risks.
Key Players & Entities
- Indivior Pharmaceuticals, Inc. (company) — Filer of the 8-K report
- 0001625297 (company) — Filer CIK number
- 0001193125-26-193925 (filing_id) — SEC Accession Number
- 2026-04-30 (date) — Period of Report and Filing Date
FAQ
What specific financial results are detailed in this 8-K filing?
The filing indicates Item 2.02 (Results of Operations and Financial Condition) was reported, and various exhibits (EX-99.1, EX-99.2, etc.) are provided, which would contain the specific financial details.
When was this 8-K filing accepted by the SEC?
The filing was accepted on April 30, 2026, at 07:00:11.
What are the main items disclosed in this 8-K?
The main items disclosed are Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits).
How many documents are included with this 8-K filing?
There are 76 documents listed for this filing.
What is the purpose of the 'EX-99.1' document mentioned?
EX-99.1 is listed as an exhibit to the 8-K filing, likely containing supplementary financial information or a press release related to the results of operations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2026 regarding Indivior Pharmaceuticals, Inc. (INDV).